TR199902727T2 - Salts of aromatic sulfonic acids. - Google Patents

Salts of aromatic sulfonic acids.

Info

Publication number
TR199902727T2
TR199902727T2 TR1999/02727T TR9902727T TR199902727T2 TR 199902727 T2 TR199902727 T2 TR 199902727T2 TR 1999/02727 T TR1999/02727 T TR 1999/02727T TR 9902727 T TR9902727 T TR 9902727T TR 199902727 T2 TR199902727 T2 TR 199902727T2
Authority
TR
Turkey
Prior art keywords
aromatic sulfonic
salts
sulfonic acids
salt
besylate
Prior art date
Application number
TR1999/02727T
Other languages
Turkish (tr)
Inventor
Johannes Heeres Gerardus
Hermanus Antonius Adreana Van Bakel Franciscus
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR199902727T2 publication Critical patent/TR199902727T2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Bulus, CNS-yatistirici, trans-5-kloro-2,3,3a,12b -tetrahidro-2-metil- 1H-dibenz[2,3:6,7] oksepino [4,5-c] pirolun bir tuzu ve bir tuz olusturucu maddedir, ikincisi de bir aromatik sülfonik asittir. Tarif edilen tuzun, tercihen besilat, uygun özellikleri vardir. Yani, besilat, depo enjeksiyon preparatlarinda kullanim açisindan uygun olabilecek istenilen çözünmezlik ve kristallesme özelliklerine sahiptir.Invention, CNS-sedative, trans-5-chloro-2,3,3a, 12b-tetrahydro-2-methyl-1H-dibenz [2,3: 6,7] oxepino [4,5-c] a salt of pyrrole and is a salt-forming agent, the second is an aromatic sulfonic acid. The described salt, preferably besylate, has suitable properties. That is, besylate has the desired insolubility and crystallization properties that may be suitable for use in depot injection preparations.

TR1999/02727T 1997-05-26 1998-05-19 Salts of aromatic sulfonic acids. TR199902727T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201596 1997-05-26

Publications (1)

Publication Number Publication Date
TR199902727T2 true TR199902727T2 (en) 2000-07-21

Family

ID=8228372

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02727T TR199902727T2 (en) 1997-05-26 1998-05-19 Salts of aromatic sulfonic acids.

Country Status (12)

Country Link
EP (1) EP0984968A1 (en)
JP (1) JP2001526702A (en)
KR (1) KR20010012985A (en)
CN (1) CN1257504A (en)
AU (1) AU7767598A (en)
BR (1) BR9809162A (en)
CA (1) CA2290070A1 (en)
HU (1) HUP0002106A3 (en)
NO (1) NO995770D0 (en)
PL (1) PL337027A1 (en)
TR (1) TR199902727T2 (en)
WO (1) WO1998054186A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101912367A (en) 2001-10-30 2010-12-15 诺瓦提斯公司 The depot formulation of iloperidone and star-shape polymer
HRP20020440B1 (en) 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
CA2581188A1 (en) * 2004-10-15 2006-04-20 Pfizer Inc. Treatment of bipolar disorders and associated symptoms
CN102596172A (en) 2009-06-24 2012-07-18 Msd欧斯股份有限公司 Injectable formulations containing asenapine and method of treatment using same
ITMI20110734A1 (en) 2011-05-02 2012-11-03 Olon Spa CRYSTALLINE ASENAPINE SALTS
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
RU2762896C2 (en) 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Transdermal therapeutic system containing asenapine
RU2764443C2 (en) 2016-12-20 2022-01-17 Лтс Ломанн Терапи-Систем Аг Transdermal therapeutic system containing azenapine and polysiloxane or polyisobutylene
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
CN112704672A (en) 2018-06-20 2021-04-27 罗曼治疗系统股份公司 Transdermal therapeutic system comprising asenapine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (en) * 1976-05-24 1977-11-28 Akzo Nv NEW TETRACYCLICAL DERIVATIVES.

Also Published As

Publication number Publication date
BR9809162A (en) 2000-08-01
JP2001526702A (en) 2001-12-18
PL337027A1 (en) 2000-07-31
NO995770L (en) 1999-11-25
HUP0002106A2 (en) 2000-11-28
WO1998054186A1 (en) 1998-12-03
NO995770D0 (en) 1999-11-25
HUP0002106A3 (en) 2001-11-28
CA2290070A1 (en) 1998-12-03
CN1257504A (en) 2000-06-21
EP0984968A1 (en) 2000-03-15
AU7767598A (en) 1998-12-30
KR20010012985A (en) 2001-02-26

Similar Documents

Publication Publication Date Title
TR199902727T2 (en) Salts of aromatic sulfonic acids.
AU3261193A (en) Amino acid derivatives as paf-receptor antagonists
AU634526B2 (en) Amino acid derivatives
DK286389D0 (en) AMINO ACID DERIVATIVES
NO890921D0 (en) PROCEDURE FOR THE PREPARATION OF AMINO ACID DERIVATIVES.
DE69323428D1 (en) CONTROLLED RELEASE MORPHIN PREPARATIONS
AU646640B2 (en) Amino acid derivatives
FI964253A0 (en) Collagen preparation for controlled release of active substances
PT91046A (en) PROCESS FOR THE PREPARATION OF ALKYLAMINOCARBONYL AMINODYOL DERIVATIVES OF AMINO ACIDS, USES AS ANTIHYPERTENSIVE AGENTS
TR199900186T2 (en) Substituted bisindolylmaleimides for inhibition of cell proliferation
IT1232828B (en) ADDITION SALTS WITH ACIDS OF N-ACYLATED DERIVATIVES OF TAURINE OR GLYCINE, THEIR PREPARATION AND USE
KR900009557A (en) Preparation of amino acid methyl ester inorganic acid salt
AU5252290A (en) Amino acid derivatives
DE69309901D1 (en) AMINO ACID DERIVATIVES WITH ANTICHOLECYSTOKININE EFFECT
BR9713087A (en) Stabilized pharmaceutical composition, use and process to prepare it, and use of methanesulfonic acid or hydrochloric acid
DE69018816T2 (en) AMINO ACID DERIVATIVES.
GB8912427D0 (en) Sulphonic acids and their salts
AU634219B2 (en) Amino acid derivatives
KR900012610A (en) Preparation for injection of substituted hexenic acid derivatives
IL106784A0 (en) Benzimidazole sulfonic acid derivatives,their preparation and their use as microbicides
IT1221492B (en) ACIDS 7- (1-PIRRIL) -E 7- (1-PIRROLI-DINIL) -6-FLUORO-1-ETHYL-1,4-DIIDRO-4-KETOCHINOLIN-3-CARBOXYLS WITH ANTI-MICROBIAL ACTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM
MX15142A (en) AMINO ACID DERIVATIVES AND PROCEDURE FOR ITS PREPARATION.
HUP9601278A3 (en) Process for the preparation of 2-fluorcyclopropylamine sulphonic acid salts and 2-fluorcyclopropylisocyanates
AU6311890A (en) Amino acid derivatives
BR1101026A (en) Derivatives of glutamic n- (5,6,7,8-tetrahydropyride [2,3-d] pyrimidin-6-ylethyl-thienyl and furylcarbonyl) acid